Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer

Mark N. Adams, Joshua T. Burgess, Yaowu He, Kathy Gately, Cameron Snell, Shu-Dong Zhang, John D. Hooper, Derek J. Richard, Kenneth J. O’Byrne

Research output: Contribution to journalArticle

16 Citations (Scopus)
Original languageEnglish
Pages (from-to)1071-1084
JournalJournal of Thoracic Oncology
Volume12
Issue number7
DOIs
Publication statusPublished - 15 Jul 2017

Keywords

  • non-small cell lung cancer
  • CDCA3
  • cell cycle
  • senescence

Cite this

Adams, M. N., Burgess, J. T., He, Y., Gately, K., Snell, C., Zhang, S-D., Hooper, J. D., Richard, D. J., & O’Byrne, K. J. (2017). Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer. Journal of Thoracic Oncology, 12(7), 1071-1084. https://doi.org/10.1016/j.jtho.2017.04.018